CompletedNot Applicable

Modified Frailty Index for Minimally Invasive Distal Pancreatectomy

South Korea1 participantsStarted 2023-01-01

Plain-language summary

This study aims to investigate the difference in postoperative complications according to the modified Frailty Index (mFI) in patients who underwent minimally invasive distal pancreatectomy for pancreatic tumors at the Asan Medical Center's Department of Hepato-Biliary-Pancreatic Surgery from 2005 to 2019. It also seeks to confirm the utility of mFI as a predictive factor for postoperative complications in frail patients in the future.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The study population consists of patients who underwent minimally invasive distal pancreatectomy for pancreatic body or tail tumors between January 2005 and December 2019. Exclusion Criteria: * None

What they're measuring

Postoperative outcomes

Timeframe: 6 months

Trial details

NCT IDNCT05837793

SponsorSong Cheol Kim

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-04-10

View on ClinicalTrials.gov More Postoperative Complication trials